Hypopyon, High IOP, and the Limits of Therapeutic Privileges
A 58-year-old man presents on a Tuesday afternoon with a two-day history of a painful red right eye, photophobia, and blurred vision. Entering visual acuity is 20/80 in the right eye and 20/20 in the left. Slit lamp shows 3+ diffuse conjunctival injection, fine keratic precipitates, flare and cells in the anterior chamber, and a 1.5-mm hypopyon. Intraocular pressure is 32 mmHg in the right eye and 16 mmHg in the left. He has no fever, no proptosis, and no history of trauma or recent ocular surgery. The optometrist holds a Kansas license with therapeutic certification and practices 45 minutes from the nearest ophthalmologist. The patient drove himself and says he cannot return tomorrow because of work. The optometrist considers starting topical prednisolone acetate 1% every hour and oral prednisone 60 mg daily, then rechecking in three days.
1. Which parts of the proposed plan are supportable under Kansas therapeutic privileges, and which require immediate reassessment? Explain your reasoning.
Read the worked answer
The findings - hypopyon, pain, high intraocular pressure, and decreased acuity - are red flags for severe intraocular inflammation or infection, not routine anterior uveitis. Topical prednisolone may be within therapeutic privileges, but it is adjunctive and must not delay ophthalmology. Oral prednisone is a systemic corticosteroid; even where Kansas law permits certain oral agents, using it empirically here is not defensible because it can worsen infectious endophthalmitis and mask progression. The optometrist should not send the patient home for three days. Same-day ophthalmology referral is required; if unavailable locally, arrange transfer or emergency department evaluation. Document the findings, the rationale, attempts to reach ophthalmology, and the patient instructions.
2. What should the optometrist document and communicate if the patient refuses the referral?
Read the worked answer
Document capacity, the specific risks explained - permanent vision loss, infection, glaucoma - the referral offered, the patient's refusal in his own words, and the alternatives discussed. Provide written safety-net instructions and arrange the earliest possible follow-up. Do not abandon the patient; continue appropriate topical therapy only if it is within scope and does not delay definitive care. Notify the receiving ophthalmologist and primary care physician with consent or as permitted for treatment. If the patient lacks capacity or presents a danger, follow emergency procedures. The record should show that the refusal was informed, not merely that the patient declined.